CIK 0000200406 · Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221024240
- Phone
- 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,898,386
- in 3 filings
Net −$16,898,386. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Grant or award · Employee Stock Options (Right to Buy) | +89,781 | 89,781 | ||
| 2025-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Grant or award · Restricted Share Units | +5,539 | 5,539 | ||
| 2025-02-15 | Mulholland Kristen EVP, Chief HR Officer | Grant or award · Employee Stock Options (Right to Buy) | +27,951 | 27,951 | ||
| 2025-02-15 | Mulholland Kristen EVP, Chief HR Officer | Grant or award · Restricted Share Units | +1,725 | 1,725 | ||
| 2025-02-15 | Forminard Elizabeth Executive VP, General Counsel | Grant or award · Employee Stock Options (Right to Buy) | +51,688 | 51,688 | ||
| 2025-02-15 | Forminard Elizabeth Executive VP, General Counsel | Grant or award · Restricted Share Units | +3,189 | 3,189 | ||
| 2025-02-15 | Decker Robert J VP Corporate Controller | Grant or award · Employee Stock Options (Right to Buy) | +8,357 | 8,357 | ||
| 2025-02-15 | Decker Robert J VP Corporate Controller | Grant or award · Restricted Share Units | +1,031 | 1,031 | ||
| 2025-02-15 | Duato Joaquin CEO and Chairman of the Board | Grant or award · Employee Stock Options (Right to Buy) | +219,020 | 219,020 | ||
| 2025-02-15 | Duato Joaquin CEO and Chairman of the Board | Grant or award · Restricted Share Units | +13,513 | 13,513 | ||
| 2025-02-15 | Broadhurst Vanessa EVP, Global Corp Affairs | Grant or award · Employee Stock Options (Right to Buy) | +25,538 | 25,538 | ||
| 2025-02-15 | Broadhurst Vanessa EVP, Global Corp Affairs | Grant or award · Restricted Share Units | +1,576 | 1,576 | ||
| 2025-02-15 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise | +1,029 | 15,501 | ||
| 2025-02-15 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise · Restricted Share Units | −1,029 | 2,056 | ||
| 2025-02-15 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise | +607 | 91,036.87 | ||
| 2025-02-15 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise · Restricted Share Units | −607 | 1,212 | ||
| 2025-02-15 | Wolk Joseph J Exec VP, CFO | Option exercise | +1,971 | 6,113 | ||
| 2025-02-15 | Wolk Joseph J Exec VP, CFO | Option exercise · Restricted Share Units | −1,971 | 3,942 | ||
| 2025-02-14 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise | +2,806 | 17,904 | ||
| 2025-02-14 | Schmid Timothy EVP, WW Chair, MedTech | Shares withheld for taxes | −1,015 | $156.71 | $159K | 16,889 |
Page 17 of 19 · 365 trades